A May 2022 study published in the medical journal Obstetrics & Gynecology compared the safety and effectiveness of transvaginal mesh repair with native tissue repair for treating pelvic organ prolapse. The study was conducted in response to a U.S. Food and Drug Administration (FDA) mandate to research transvaginal mesh, a controversial treatment the FDA banned in 2019.

Unfortunately, questions remain despite this new research because the study did not find transvaginal mesh to be significantly superior or inferior to native tissue repair, and the FDA required a "superiority benchmark" to be met in order to reconsider this treatment option.

What is pelvic organ prolapse?

Pelvic organ prolapse (POP), also called vaginal prolapse, is a protrusion of pelvic organs, including the vagina, bladder, uterus and